Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
05/2012
05/03/2012US20120108631 Sulfonamides for the Modulation of PKM2
05/03/2012US20120108627 Imidazo [4,5-c]quinoline derivatives and their use in the treatment of tumors and/or inflammation
05/03/2012US20120108623 Beloxepin and analogs for the treatment of pain
05/03/2012US20120108618 Thia-triaza-indacenes
05/03/2012US20120108617 Methods and compositions involving (s)-bucindolol
05/03/2012US20120108616 Substituted oxazole derivatives and their use as tyrosine kinase inhibitors
05/03/2012US20120108614 Compounds and compositions for treating chemical warfare agent-induced injuries
05/03/2012US20120108613 Compounds and compositions for treating chemical warfare agent-induced injuries
05/03/2012US20120108612 Inhibitors of bruton's tyrosine kinase
05/03/2012US20120108611 5, 6-bisaryl-2-pyridine-carboxamide derivatives, preparation and application thereof in therapeutics as urotensin ii receptor antagonists
05/03/2012US20120108610 2-pyrazinone derivatives for the treatment of disease or condition in which inhibition of neutrophil elastase activity is beneficial
05/03/2012US20120108605 O-glcnac transferase inhibitors and uses thereof
05/03/2012US20120108603 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase
05/03/2012US20120108599 Methods and compositions for the treatment of metabolic disorders
05/03/2012US20120108597 Azaquinazolinediones Chymase Inhibitors
05/03/2012US20120108595 Platelet-activating factor receptor antagonists
05/03/2012US20120108594 PROCESS FOR PREPARING SALTS OF 4-[[5-[(CYCLOPROPYLAMINO)CARBONYL]-2-METHYLPHENYL]AMINO]-5-METHYL-N-PROPYLPYRROLO[2,1-f][1,2,4]TRIAZINE-6-CARBOXAMIDE AND NOVEL STABLE FORMS PRODUCED THEREIN
05/03/2012US20120108588 Novel 3-amido-pyrrolo[3,4-c]pyrazole-5(1h, 4h,6h) carbaldehyde derivatives
05/03/2012US20120108587 Aza- and Diaza-Phthalazine Compounds as P38 Map Kinase Modulators and Methods of Use Thereof
05/03/2012US20120108584 2h or 3h-benzo[e]indazol-1-yl carbamate derivatives, the preparation and therapeutic use thereof
05/03/2012US20120108583 Tricyclic Compounds As mPGES-1 Inhibitors
05/03/2012US20120108582 Fused substituted aminopyrrolidine derivative
05/03/2012US20120108571 Substituted phenoxy n-alkylated thiazolidinediones as estrogen related receptor-alpha modulators
05/03/2012US20120108568 SUBSTITUTED PYRAZOLO[1,5-a]PYRIMIDINE COMPOUNDS AS TRK KINASE INHIBITORS
05/03/2012US20120108566 Nicotinamides as jak kinase modulators
05/03/2012US20120108555 Mixtures or Organic Compounds for the Treatment of Airway Diseases
05/03/2012US20120108553 Combination Therapy with Non-Selective COX Inhibitors to Prevent COX-Related Gastric Injuries
05/03/2012US20120108550 Use of Derivatives of Polyunsaturated Fatty Acids as Medicaments
05/03/2012US20120108549 Neuroprotective compounds and their use
05/03/2012US20120108548 Molecular tweezers for the treatment of amyloid-related diseases
05/03/2012US20120108534 Dihydrothienopyrimidines for the treatment of inflammatory Diseases
05/03/2012US20120108528 New therapeutic approaches for treating neuroinflammatory conditions
05/03/2012US20120108509 Artificial scab for use in an airway
05/03/2012US20120108494 Inhibitors of intracellular urokinase plasminogen activator and methods of use thereof
05/03/2012US20120107897 Double-stranded oligonucleotides
05/03/2012US20120107833 Antibody specific for a mammalian sphingosine kinase type 2 isoform protein and methods of use thereof
05/03/2012US20120107406 Dry Powder Formulations
05/03/2012US20120107404 Crystalline Pharmaceutical and Methods of Preparation and Use Thereof
05/03/2012US20120107400 Sustained release composition of theraputic agent
05/03/2012US20120107380 Methods of saponifying xanthophyll esters and isolating xanthophylls
05/03/2012US20120107336 Modified defensins and their use
05/03/2012US20120107330 Antagonists, uses & methods for partially inhibiting tnfr1
05/03/2012US20120107328 Gamma secretase modulators
05/03/2012US20120107325 IL-17 Antagonistic Antibodies
05/03/2012US20120107317 Use of cytoplasmic c-myc for regulating immune responses
05/03/2012US20120107298 Use of LCAT for Treating Anemia and Red Blood Cell Dysfunction
05/03/2012US20120107290 Non-replicating micro-organisms and their immune boosting effect
05/03/2012US20120107287 Specialized medical nutrition for surgical and trauma patients containing probiotics
05/03/2012US20120107273 New piperazine compound and use thereof as a hcv polymerase inhibitor
05/03/2012US20120107269 Thiophene derivatives
05/03/2012US20120107254 Long Wear Topical Composition
05/03/2012US20120107252 Method for forming cyclodextrin polymer and lipophilic compound emulsions, resulting emulsions, and compositions including said emulsions
05/03/2012US20120107251 Oregano oral care compositions and methods of use thereof
05/03/2012US20120107230 Treatment of Hyperproliferative Diseases with Vinca Alkaloid N-Oxide Analogs
05/03/2012CA2828238A1 Therapeutic use of dimiracetam to prevent the hand & foot syndrome caused by sorafenib
05/03/2012CA2815170A1 Pyridine derivative and medicinal agent
05/03/2012CA2814768A1 Oxazoline and isoxazoline derivatives as crac modulators
05/03/2012CA2814371A1 Use of malononitrilamides in neuropathic pain
05/02/2012EP2447266A1 Pyrimidopyridine compound used as a CSBP/RK/p38 modulator
05/02/2012EP2447249A1 N-phenyl-1-sulfonyl-2-pyrrolidine carboxamide libraries for drug discovery
05/02/2012EP2446903A2 Methods, compositions, and kits for treating pain and pruritis
05/02/2012EP2446883A1 Treatment of inflammation
05/02/2012EP2445914A1 DERIVATIVES OF 6,7-DIHYDRO-5H-IMIDAZO[1,2-a]IMIDAZOLE-3-CARBOXYLIC ACID AMIDES
05/02/2012EP2445912A1 Novel compound useful for the treatment of degenerative and inflammatory diseases
05/02/2012EP2445909A1 DERIVATIVES OF 6,7-DIHYDRO-5H-IMIDAZO[1,2-a]IMIDAZOLE-3-CARBOXYLIC ACID AMIDES
05/02/2012EP2445898A2 4h-pyrido[1,2-a]pyrimidin-4-one derivatives as pi3k inhibitors
05/02/2012EP2445897A1 Novel indole, indazole and benzimidazole arylamides as p2x3 and/or p2x2/3 antagonists
05/02/2012EP2445886A1 Heterocyclic compounds and their uses
05/02/2012EP2445861A1 Novel acetylsalicylic acid salts
05/02/2012EP2445521A2 Albumin-free botulinum toxin formulations
05/02/2012EP2445499A1 Method for treating a patient at risk for developing an nsaid-associated ulcer
05/02/2012EP2445344A1 Method for treating a patient in need of aspirin therapy
05/02/2012EP2124977B9 Method for treating or preventing systemic inflammation
05/02/2012EP2102161B1 Processes for the preparation of 3-(4-(2,4-difluorobenzyloxy)-3-bromo-6-methyl- 2-oxopyridin-1(2H)-yl)-N,4-dimethylbenzamide
05/02/2012EP1955697B1 2-aminobenzamide derivatives as vanilloid receptor 1 (vr1) inhibitors useful for the treatment of pain or bladder function disorder
05/02/2012EP1861403B1 Novel imidazo[1,5-a]pyridine derivatives, method for preparing same and pharmaceutical compositions containing same
05/02/2012EP1756120B1 Purine derivative
05/02/2012EP1716851B1 Thioamides and salts thereof and cytokine production inhibitors containing both
05/02/2012EP1627869B1 Vanilloid receptor modulators
05/02/2012EP1534668B1 Crystalline solid form of (2s-5z)-2-amino-7-(ethanimidoylamino)-2-methylhept-5-enoic acid
05/02/2012EP1517905B1 Processes for preparing substituted pyrimidines and pyrimidine derivatives as inhibitors of protein kinases
05/02/2012EP1429723B1 Treating effects of excessive reactive oxygen species
05/02/2012CN202207239U Novel wound plaster
05/02/2012CN102439022A Novel sodium channel blocking compounds tetrodotoxin galactopyranosides
05/02/2012CN102439021A Novel galactoside inhibitors of galectins
05/02/2012CN102439011A Toll-like receptor modulators and treatment of diseases
05/02/2012CN102439007A Amide derivative
05/02/2012CN102438991A Carbinol compound having heterocyclic linker
05/02/2012CN102438986A Isoquinolin-1 (2h) -one derivatives as parp-1 inhibitors
05/02/2012CN102438983A Compounds for treating inflammation and pain
05/02/2012CN102438979A New crystals of a benzoylbenzeneacetamide derivative
05/02/2012CN102438975A Substituted aromatic compounds and pharmaceutical uses thereof
05/02/2012CN102438645A Therapeutic modulation of vaginal epithelium boundary lubrication
05/02/2012CN102438641A Elastase inhibitor
05/02/2012CN102438627A A novel formulation of meloxicam
05/02/2012CN102438624A Substituted fused pyrimidine compounds
05/02/2012CN102438614A Pyrone analogs for therapeutic treatment
05/02/2012CN102438613A Anti-inflammatory composition containing macrolactin a and a derivative thereof as active ingredients
05/02/2012CN102432603A Preparation method and pharmacological effect of mangiferin hexa-butyl-esterified derivative
05/02/2012CN102432602A Mangiferin hepta-propyl-esterified derivative
1 ... 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 ... 1272